Assessment of the Influence of Early Preoperative Consultation on Satisfaction and the Average Length of Stay of Patients Who Underwent Total Hip Arthroplasty
PTHJ-8
Prospective Randomized Assessment of the Influence of Early Preoperative Consultation on Satisfaction and the Average Length of Stay of Patients Who Underwent Total Hip Arthroplasty
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Arthroplastic hip surgery "fast-track" the subject of increasing interest and reduces the average length of stay and improve patient satisfaction. This fast circuit implemented in many schools uses dedicated inpatient units, preoperative patient education in multidisciplinary groups (including physiotherapists, nurses, rehabilitation doctors and surgeons), an analgesia protocol multimodal and a network dedicated to the outlet (1.2). The investigators working hypothesis is that the mere realization of a preoperative visit a week before the intervention would reduce the average length of stay for all patients with a target of two nights (instead of 7.5 days currently) (3) to reduce the use of SSR during hospitalization. This consultation would serve to explain to the patient the early course of care, give advice and help to anticipate acts for its release "post-operative" as, for example, contact a physical therapist and a nurse or check to their community pharmacy if their heparin stock is enough and to answer any questions (Appendix 2: early information given to the patient consultation J-8). The investigators protocol is inspired by the one already in place for outpatient PTH and PTH 1 night but invariably apply to all patients for whom a home is considered output.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 9, 2016
CompletedFirst Posted
Study publicly available on registry
May 12, 2016
CompletedFebruary 23, 2017
May 1, 2016
7 months
May 9, 2016
February 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Average length of stay
After surgery at Day 1
Secondary Outcomes (6)
OXFORD Score for Hip
Before and after surgery at Day -1 then Day 1
Patient satisfaction (verbal scale: 0 to 10)
Before and after surgery at Day -1 then Day 1
St. Joseph Satisfaction
After surgery when leaving the hospital, in average in the 3 Days
Evaluation of pain by VAS
Before and after surgery at Day -1 then Day 1
Morbidity
In the week after surgery
- +1 more secondary outcomes
Study Arms (2)
Group with D-8 medical consultation
EXPERIMENTALA medical consultation 8 days before surgery would serve to explain to the patient the early course of care, give advice and help to anticipate acts for its release "post-operative" as, for example, contact a physical therapist and a nurse or check to their community pharmacy if their heparin stock is enough and to answer any questions.
Group without D-8 medical consultation
NO INTERVENTIONInterventions
This consultation would serve to explain to the patient the early course of care, give advice and help to anticipate acts for its release "post-operative" as, for example, contact a physical therapist and a nurse or check to their community pharmacy if their heparin stock is enough and to answer any questions.
Eligibility Criteria
You may qualify if:
- \. All patients undergoing total hip replacement
You may not qualify if:
- Patient choosing immediately a supported SSR in postoperative
- Geographical remoteness
- Social isolation
- Medical pathology requiring special monitoring (phlebitis history, coagulation disorders, anticoagulant therapy ...)
- psychiatric pathology
- Patients opting for the protocol "overnight"
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume RIOUALLON, MD
Groupe Hospitalier Paris Saint-Joseph (FRANCE)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2016
First Posted
May 12, 2016
Study Start
September 23, 2015
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
February 23, 2017
Record last verified: 2016-05